11β-hydroxysteroid dehydrogenase type 1 is expressed in human sebaceous glands and regulates glucocorticoid-induced lipid synthesis and toll-like receptor 2 expression in SZ95 sebocytes

Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients

(2011) René Baudrand et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

11β-Hydroxysteroid Dehydrogenase-1 Is a Novel Regulator of Skin Homeostasis and a Candidate Target for Promoting Tissue Repair

(2011) Mika Terao et al.   PLoS One

Die Talgdrüse

(2010) C.C. Zouboulis   HAUTARZT

Localization, Age- and Site-Dependent Expression, and Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 in Skin

(2010) Ana Tiganescu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Glucocorticoids Enhance Toll-Like Receptor 2 Expression in Human Keratinocytes Stimulated with Propionibacterium acnes or Proinflammatory Cytokines

(2008) Michio Shibata et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Glucocorticoid Regulation of the Promoter of 11β-Hydroxysteroid Dehydrogenase Type 1 Is Indirect and Requires CCAAT/Enhancer-Binding Protein-β

(2008) Shuji Sai et al.   MOLECULAR ENDOCRINOLOGY

Suppression of 11β-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis

(2007) Yong Liu et al.   PHYSIOLOGICAL GENOMICS